Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN CARBOGEN AMCIS vs BLISS GVS PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DISHMAN CARBOGEN AMCIS BLISS GVS PHARMA DISHMAN CARBOGEN AMCIS/
BLISS GVS PHARMA
 
P/E (TTM) x -23.9 13.1 - View Chart
P/BV x 0.6 1.3 47.2% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 DISHMAN CARBOGEN AMCIS   BLISS GVS PHARMA
EQUITY SHARE DATA
    DISHMAN CARBOGEN AMCIS
Mar-23
BLISS GVS PHARMA
Mar-23
DISHMAN CARBOGEN AMCIS/
BLISS GVS PHARMA
5-Yr Chart
Click to enlarge
High Rs20191 220.4%   
Low Rs8067 118.9%   
Sales per share (Unadj.) Rs153.972.2 213.3%  
Earnings per share (Unadj.) Rs-1.97.4 -25.8%  
Cash flow per share (Unadj.) Rs16.09.2 174.7%  
Dividends per share (Unadj.) Rs00.50 0.0%  
Avg Dividend yield %00.6 0.0%  
Book value per share (Unadj.) Rs370.684.0 441.1%  
Shares outstanding (eoy) m156.78104.15 150.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.91.1 83.2%   
Avg P/E ratio x-74.010.8 -687.5%  
P/CF ratio (eoy) x8.88.7 101.5%  
Price / Book Value ratio x0.40.9 40.2%  
Dividend payout %06.8 -0.0%   
Avg Mkt Cap Rs m22,0598,262 267.0%   
No. of employees `000NANA-   
Total wages/salary Rs m10,353862 1,201.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m24,1297,516 321.0%  
Other income Rs m278178 156.1%   
Total revenues Rs m24,4077,694 317.2%   
Gross profit Rs m2,8411,173 242.1%  
Depreciation Rs m2,807187 1,503.3%   
Interest Rs m857104 826.8%   
Profit before tax Rs m-5461,061 -51.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-248293 -84.5%   
Profit after tax Rs m-298767 -38.8%  
Gross profit margin %11.815.6 75.4%  
Effective tax rate %45.427.7 164.2%   
Net profit margin %-1.210.2 -12.1%  
BALANCE SHEET DATA
Current assets Rs m19,1846,974 275.1%   
Current liabilities Rs m17,9841,933 930.6%   
Net working cap to sales %5.067.1 7.4%  
Current ratio x1.13.6 29.6%  
Inventory Days Days7139 182.8%  
Debtors Days Days91,871 0.5%  
Net fixed assets Rs m75,2114,562 1,648.8%   
Share capital Rs m314104 301.1%   
"Free" reserves Rs m57,7838,646 668.3%   
Net worth Rs m58,0978,750 664.0%   
Long term debt Rs m10,467407 2,572.3%   
Total assets Rs m94,39511,535 818.3%  
Interest coverage x0.411.2 3.2%   
Debt to equity ratio x0.20 387.4%  
Sales to assets ratio x0.30.7 39.2%   
Return on assets %0.67.6 7.8%  
Return on equity %-0.58.8 -5.8%  
Return on capital %0.512.7 3.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3,9805,618 70.8%   
Fx outflow Rs m7611,225 62.2%   
Net fx Rs m3,2194,394 73.3%   
CASH FLOW
From Operations Rs m2,203343 642.1%  
From Investments Rs m-4,485-78 5,785.8%  
From Financial Activity Rs m2,497-249 -1,001.1%  
Net Cashflow Rs m21630 713.6%  

Share Holding

Indian Promoters % 59.3 35.0 169.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 12.3 22.0 55.9%  
FIIs % 8.6 15.4 56.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 40.7 65.0 62.6%  
Shareholders   52,336 40,758 128.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DISHMAN CARBOGEN AMCIS With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on DISHMAN CARBOGEN AMCIS vs BLISS GVS PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

DISHMAN CARBOGEN AMCIS vs BLISS GVS PHARMA Share Price Performance

Period DISHMAN CARBOGEN AMCIS BLISS GVS PHARMA S&P BSE HEALTHCARE
1-Day 0.73% -1.31% 1.18%
1-Month -5.70% -9.12% -0.75%
1-Year 89.09% 58.26% 61.82%
3-Year CAGR 29.43% 3.89% 18.16%
5-Year CAGR 2.43% -8.75% 19.79%

* Compound Annual Growth Rate

Here are more details on the DISHMAN CARBOGEN AMCIS share price and the BLISS GVS PHARMA share price.

Moving on to shareholding structures...

The promoters of DISHMAN CARBOGEN AMCIS hold a 59.3% stake in the company. In case of BLISS GVS PHARMA the stake stands at 35.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of DISHMAN CARBOGEN AMCIS and the shareholding pattern of BLISS GVS PHARMA.

Finally, a word on dividends...

In the most recent financial year, DISHMAN CARBOGEN AMCIS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

BLISS GVS PHARMA paid Rs 0.5, and its dividend payout ratio stood at 6.8%.

You may visit here to review the dividend history of DISHMAN CARBOGEN AMCIS, and the dividend history of BLISS GVS PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.